{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:06:17Z","timestamp":1794380777854,"version":"4.9.0"},"publisher-location":"Totowa, NJ","reference-count":19,"publisher":"Humana Press","isbn-type":[{"value":"9781607617990","type":"print"},{"value":"9781607618003","type":"electronic"}],"license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.1007\/978-1-60761-800-3_11","type":"book-chapter","created":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T17:51:35Z","timestamp":1283881895000},"page":"221-243","source":"Crossref","is-referenced-by-count":3,"title":["Systems Biology Approaches to the Study of Cardiovascular Drugs"],"prefix":"10.1007","author":[{"given":"Yuri","family":"Nikolsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kleemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,27]]},"reference":[{"key":"11_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2174\/156800605774962077","volume":"5","author":"R Kleemann","year":"2005","unstructured":"Kleemann R, Kooistra T (2005) HMG-CoA reductase inhibitors: effects on chronic subacute inflammation and onset of atherosclerosis induced by dietary cholesterol. Curr Drug Targets Cardiovasc Haematol Disord 5:441\u2013453","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"11_CR2","doi-asserted-by":"publisher","first-page":"R200","DOI":"10.1186\/gb-2007-8-9-r200","volume":"8","author":"R Kleemann","year":"2007","unstructured":"Kleemann R, Verschuren L, van Erk MJ et al (2007) Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis. Genome Biol 8:R200","journal-title":"Genome Biol"},{"key":"11_CR3","doi-asserted-by":"publisher","first-page":"42774","DOI":"10.1074\/jbc.M306022200","volume":"278","author":"L Vergnes","year":"2003","unstructured":"Vergnes L, Phan J, Strauss M, Tafuri S, Reue K (2003) Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J Biol Chem 278:42774\u201342784","journal-title":"J Biol Chem"},{"key":"11_CR4","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1161\/01.ATV.0000238348.05028.14","volume":"26","author":"T Kooistra","year":"2006","unstructured":"Kooistra T, Verschuren L, de Vries-van der Weij J et al (2006) Fenofibrate reduces atherogenesis in ApoE*3Leiden mice: evidence for multiple antiatherogenic effects besides lowering plasma cholesterol. Arterioscler Thromb Vasc Biol 26:2322\u20132330","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"11_CR5","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1161\/CIRCULATIONAHA.104.506188","volume":"111","author":"LR Tannock","year":"2005","unstructured":"Tannock LR, O\u2019Brien KD, Knopp RH et al (2005) Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects. Circulation 111:3058\u20133062","journal-title":"Circulation"},{"key":"11_CR6","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1001\/jama.294.20.joc50147","volume":"294","author":"SE Nissen","year":"2005","unstructured":"Nissen SE, Wolski K, Topol EJ (2005) Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus. JAMA 294:2581\u20132586","journal-title":"JAMA"},{"key":"11_CR7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1517\/14656566.9.6.875","volume":"9","author":"SA Doggrell","year":"2008","unstructured":"Doggrell SA (2008) The failure of torcetrapib: is there a case for independent preclinical and clinical testing? Expert Opin Pharmacother 9:875\u2013878","journal-title":"Expert Opin Pharmacother"},{"key":"11_CR8","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/S0140-6736(07)60716-8","volume":"370","author":"J Armitage","year":"2007","unstructured":"Armitage J (2007) The safety of statins in clinical practice. Lancet 370:1781\u20131790","journal-title":"Lancet"},{"key":"11_CR9","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.bbalip.2007.02.003","volume":"1771","author":"A Rubenstrunk","year":"2007","unstructured":"Rubenstrunk A, Hanf R, Hum DW, Fruchart JC, Staels B (2007) Safety issues and prospects for future generations of PPAR modulators. Biochim Biophys Acta 1771:1065\u20131081","journal-title":"Biochim Biophys Acta"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.2337\/db06-1059","volume":"56","author":"SS Choe","year":"2007","unstructured":"Choe SS, Choi AH, Lee JW et al (2007) Chronic activation of liver X receptor induces beta-cell apoptosis through hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic beta-cells. Diabetes 56:1534\u20131543","journal-title":"Diabetes"},{"key":"11_CR11","volume-title":"Functional analysis of OMICs data and small molecule compounds in an integrated \u201cknowledge-based\u201d platform. From the \u201cProtein networks and pathway analysis\u201d book","author":"Y Nikolsky","year":"2009","unstructured":"Nikolsky Y, Kirillov E, Zuev R, Rakhmatulin E, Nikolskaya T (2009) Functional analysis of OMICs data and small molecule compounds in an integrated \u201cknowledge-based\u201d platform. From the \u201cProtein networks and pathway analysis\u201d book. Humana, UK"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1194\/jlr.M800374-JLR200","volume":"50","author":"L Verschuren","year":"2009","unstructured":"Verschuren L, de Vries-van der Weij J, Zadelaar S, Kleemann R, Kooistra T (2009) LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in ApoE*3Leiden mice: time course and mechanisms. J Lipid Res 50:301\u2013311","journal-title":"J Lipid Res"},{"key":"11_CR13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1210\/me.2003-0061","volume":"17","author":"P Tontonoz","year":"2003","unstructured":"Tontonoz P, Mangelsdorf DJ (2003) Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 17:985\u2013993","journal-title":"Mol Endocrinol"},{"key":"11_CR14","doi-asserted-by":"crossref","unstructured":"The Gene Ontology project in 2008 (2008) Nucleic Acids Res 36:D440\u2013D444","DOI":"10.1093\/nar\/gkm883"},{"key":"11_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2199-7-3","volume":"7","author":"A Schroeder","year":"2006","unstructured":"Schroeder A, Mueller O, Stocker S et al (2006) The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7:3","journal-title":"BMC Mol Biol"},{"key":"11_CR16","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1161\/ATVBAHA.107.142570","volume":"27","author":"S Zadelaar","year":"2007","unstructured":"Zadelaar S, Kleemann R, Verschuren L et al (2007) Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler Thromb Vasc Biol 27:1706\u20131721","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"11_CR17","first-page":"755","volume":"26","author":"AE Black","year":"1998","unstructured":"Black AE, Sinz MW, Hayes RN, Woolf TF (1998) Metabolism and excretion studies in mouse after single and multiple oral doses of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin. Drug Metab Dispos 26:755\u2013763","journal-title":"Drug Metab Dispos"},{"key":"11_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1161\/CIRCRESAHA.109.199166","volume":"105","author":"L Verschuren","year":"2009","unstructured":"Verschuren L, Kooistra T, Bernhagen J et al (2009) MIF-deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance and associated atherosclerotic disease. Circ Res 105:99\u2013107","journal-title":"Circ Res"},{"key":"11_CR19","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/cvr\/cvn120","volume":"79","author":"R Kleemann","year":"2008","unstructured":"Kleemann R, Zadelaar S, Kooistra T (2008) Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 79:360\u2013376","journal-title":"Cardiovasc Res"}],"container-title":["Methods in Molecular Biology","Systems Biology in Drug Discovery and Development"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-60761-800-3_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T02:17:22Z","timestamp":1557800242000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-60761-800-3_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"ISBN":["9781607617990","9781607618003"],"references-count":19,"URL":"https:\/\/doi.org\/10.1007\/978-1-60761-800-3_11","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-60761-800-3","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}